XML 130 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Balance at Dec. 31, 2016 $ 459,740 $ 274 $ 345,138 $ 117,049 $ (2,721)
Balance (in shares) at Dec. 31, 2016   27,798,283      
Increase (Decrease) in Stockholders' Equity          
Net Income 60,100     60,100  
Other comprehensive income (loss) 3,136       3,136
Share-based compensation expense 5,809   5,809    
Issuance of restricted stock, net (in shares)   166,397      
Issuance of common stock 709,377 $ 181 709,196    
Issuance of common stock (in shares)   17,954,274      
Goodwill adjustment 500   500    
Restricted stock surrendered and canceled (1,258)   (1,258)    
Restricted stock surrendered and canceled (in shares)   (21,537)      
Exercise of stock options, net 4,592 $ 3 4,589    
Exercise of stock options (in shares)   347,633      
Balance at Dec. 31, 2017 1,241,996 $ 458 1,063,974 177,149 415
Balance (in shares) at Dec. 31, 2017   46,245,050      
Increase (Decrease) in Stockholders' Equity          
Net Income 123,340     123,340  
Other comprehensive income (loss) (6,098)       (6,098)
Share-based compensation expense 9,033   9,033    
Issuance of restricted stock, net 0        
Issuance of restricted stock, net (in shares)   270,571      
Issuance of common stock 601,171 $ 158 601,013    
Issuance of common stock (in shares)   15,758,039      
Restricted stock surrendered and canceled (1,669)   (1,669)    
Restricted stock surrendered and canceled (in shares)   (33,148)      
Exercise of stock options, net 1,924 $ 1 1,923    
Exercise of stock options (in shares)   240,243      
Reclassification of certain tax effects of the Tax Cuts and Jobs Act 0     (82) 82
Balance at Dec. 31, 2018 $ 1,969,697 $ 617 1,674,274 300,407 (5,601)
Balance (in shares) at Dec. 31, 2018 62,480,755 62,480,755      
Increase (Decrease) in Stockholders' Equity          
Net Income $ 159,718     159,718  
Other comprehensive income (loss) 27,124       27,124
Share-based compensation expense 10,528   10,528    
Issuance of restricted stock, net 0        
Issuance of restricted stock, net (in shares)   316,754      
Restricted stock surrendered and canceled (3,285)   (3,285)    
Restricted stock surrendered and canceled (in shares)   (139,569)      
Repurchase and retirement of common stock (100,000) $ (33) (89,887) (10,080)  
Repurchase of common stock (in shares)   (3,364,761)      
Cash dividends declared ($0.88 per share) (53,867)     (53,867)  
Dividend equivalents declared ($0.88 per restricted stock units) 0   127 (127)  
Exercise of stock options, net 2,679 $ 2 2,677    
Exercise of stock options (in shares)   212,878      
Balance at Dec. 31, 2019 $ 2,012,594 $ 586 $ 1,594,434 $ 396,051 $ 21,523
Balance (in shares) at Dec. 31, 2019 59,506,057 59,506,057